Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-075174
Filing Date
2011-08-09
Accepted
2011-08-09 17:07:32
Documents
8
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c19801e10vq.htm 10-Q 207014
2 EXHIBIT 31.1 c19801exv31w1.htm EX-31.1 5983
3 EXHIBIT 32.1 c19801exv32w1.htm EX-32.1 2587
  Complete submission text file 0000950123-11-075174.txt   1139459

Data Files

Seq Description Document Type Size
4 EX-101 INSTANCE DOCUMENT inhx-20110630.xml EX-101.INS 108412
5 EX-101 SCHEMA DOCUMENT inhx-20110630.xsd EX-101.SCH 7725
6 EX-101 CALCULATION LINKBASE DOCUMENT inhx-20110630_cal.xml EX-101.CAL 26891
7 EX-101 LABELS LINKBASE DOCUMENT inhx-20110630_lab.xml EX-101.LAB 93708
8 EX-101 PRESENTATION LINKBASE DOCUMENT inhx-20110630_pre.xml EX-101.PRE 58323
Mailing Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004
Business Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004 678-746-1100
INHIBITEX, INC. (Filer) CIK: 0001274913 (see all company filings)

EIN.: 742708737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50772 | Film No.: 111021758
SIC: 2836 Biological Products, (No Diagnostic Substances)